Oncobiologics (OTLK)
(Delayed Data from NSDQ)
$6.00 USD
0.00 (0.00%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $5.98 -0.02 (-0.33%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 12/27/24 |
---|---|
Current Quarter | -0.84 |
EPS Last Quarter | -0.83 |
Last EPS Surprise | 21.70% |
ABR | 1.14 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.59 |
Next Year | -2.02 |
EPS (TTM) | -4.18 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 7.44M |
# of Estimates | NA | NA | NA | 4 |
High Estimate | NA | NA | NA | 10.87M |
Low Estimate | NA | NA | NA | 4.80M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.84 | -0.81 | -3.59 | -2.02 |
# of Estimates | 3 | 2 | 3 | 3 |
Most Recent Consensus | -0.89 | -0.62 | -3.73 | -1.64 |
High Estimate | -0.76 | -0.62 | -3.01 | -1.64 |
Low Estimate | -0.89 | -0.99 | -4.04 | -2.24 |
Year ago EPS | -1.00 | -0.80 | -4.80 | -3.59 |
Year over Year Growth Est. | 16.00% | -1.25% | 25.21% | 43.73% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 2 | 1 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Current | -0.84 | -0.81 | -3.59 | -2.02 |
7 Days Ago | -0.84 | -0.81 | -3.59 | -2.02 |
30 Days Ago | -0.84 | -0.99 | -3.65 | -2.22 |
60 Days Ago | -0.86 | -1.00 | -3.80 | -2.19 |
90 Days Ago | -0.86 | -1.00 | -3.80 | -2.19 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.84 | -0.62 | -3.73 | -1.64 |
Zacks Consensus Estimate | -0.84 | -0.81 | -3.59 | -2.02 |
Earnings ESP | 0.00% | 22.98% | -3.80% | 18.94% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.83 | -1.55 | -0.80 | -1.00 | NA |
Estimate | -1.06 | -0.88 | -1.00 | -1.00 | NA |
Difference | 0.23 | -0.67 | 0.20 | 0.00 | -0.06 |
Surprise | 21.70% | -76.14% | 20.00% | 0.00% | -8.61% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more